Description

Semaglutide is a GLP‑1 receptor agonist commonly studied for its role in appetite regulation, metabolic function, and blood‑sugar control. Known as main active ingredient in Ozempic.

For research and lab use only.

Observed Benefits
• May assist research on appetite reduction and satiety
• May support glucose‑handling and insulin‑response studies
• May influence cardiovascular‑related biomarkers in research
• May help explore weight‑regulation pathways